SYNTHESIS AND DISTRIBUTION OF ATRIAL-NATRIURETIC-PEPTIDE (ANP) IN HEARTS FROM NORMAL DOGS AND THOSE WITH CARDIAC ABNORMALITIES

被引:11
|
作者
COLBATZKY, F [1 ]
VOLLMAR, A [1 ]
MONCH, U [1 ]
HERMANNS, W [1 ]
机构
[1] UNIV MUNICH,INST PHARMACOL TOXICOL & PHARM,W-8000 MUNICH 22,GERMANY
关键词
D O I
10.1016/S0021-9975(08)80218-6
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
The cardiac distribution of immunoreactive atrial natriuretic peptide (IR-ANP) and ANP-specific mRNA was studied in 35 normal dogs and 44 dogs with primary and secondary heart abnormalities. According to clinical and pathological findings the clogs were assigned to seven groups; Group 1, normal young clogs (< 12 months); Group 2, normal adult dogs (〉 12 months); Group 3, low to moderate hypertrophy; Group 4, severe hypertrophy; Group 5, dilated cardiomyopathy; Group 6, renal failure with secondary left ventricular hypertrophy; and Group 7, other heart abnormalities. In comparison with hearts of normal dogs, the amount of IR-ANP and ANP-specific mRNA was reduced in the atria and increased in the ventricles of clogs with hypertrophy and cardiomyopathy, The immunoreactivity in normal canine atria was far lower than in control rats and hamsters. The pattern of ventricular immunoreactivity was faint and patchy. Only in a flew ventricular localizations of three dogs of Group 5 and one dog of Group 6 was there a granular pattern suggesting the presence of secretory granules, A state of intense secretory stimulation in cardiomyopathy was indicated by electron microscopy. Due to its low concentration and localized pattern, however, IR-ANP does not seem to be a reliable marker for the presence of hypertrophic or cardiomyopathic changes in dogs. © 1993, Academic Press Limited. All rights reserved.
引用
收藏
页码:149 / 163
页数:15
相关论文
共 50 条
  • [31] ATRIAL-NATRIURETIC-PEPTIDE RELEASE IN CALVES WITH ARTIFICIAL HEARTS
    WESTENFELDER, C
    BARANOWSKI, RL
    KABLITZ, C
    OLSEN, DB
    BURNS, G
    JAHAN, S
    [J]. CLINICAL RESEARCH, 1986, 34 (01): : A110 - A110
  • [32] RENAL EFFECTS OF URODILATIN (UDL) AND ATRIAL-NATRIURETIC-PEPTIDE (ANP) IN VOLUME EXPANDED CONSCIOUS DOGS
    BESTLE, MH
    BIE, P
    [J]. ACTA PHYSIOLOGICA SCANDINAVICA, 1991, 143 (01): : A15 - A15
  • [33] PLASMA ATRIAL-NATRIURETIC-PEPTIDE (ANP) LEVELS AT BIRTH IN SWINE
    CONDEMI, G
    ZEBALLOS, G
    HUNDLEY, BW
    RAO, PS
    GOOTMAN, PM
    [J]. FASEB JOURNAL, 1991, 5 (04): : A392 - A392
  • [34] ROLE OF ATRIAL-NATRIURETIC-PEPTIDE (ANP) IN MINERALOCORTICOID ESCAPE IN THE DOG
    BAXTER, JD
    GARDNER, DG
    METZLER, CH
    RAMSAY, DJ
    THRASHER, TN
    [J]. JOURNAL OF PHYSIOLOGY-LONDON, 1986, 371 : P249 - P249
  • [35] ATRIAL-NATRIURETIC-PEPTIDE (ANP) RECEPTORS IN GENETIC-HYPERTENSION
    MITTAL, CK
    [J]. FASEB JOURNAL, 1992, 6 (04): : A1584 - A1584
  • [36] RADIOIMMUNOASSAY OF ATRIAL-NATRIURETIC-PEPTIDE (ANP) AND CHARACTERIZATION OF ANP IMMUNOREACTIVITY IN HUMAN PLASMA AND ATRIAL TISSUE
    LINDBERG, BF
    NILSSON, LG
    BERGQUIST, S
    ANDERSSON, KE
    [J]. SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 1992, 52 (06): : 447 - 456
  • [37] EFFECTS OF DIETARY MAGNESIUM ON ATRIAL-NATRIURETIC-PEPTIDE (ANP) RELEASE
    WONG, NLM
    WONG, EFC
    HU, DCK
    [J]. KIDNEY INTERNATIONAL, 1990, 37 (01) : 344 - 344
  • [38] PHYSIOLOGICAL AND PHARMACOLOGICAL MEDIATORS OF ATRIAL-NATRIURETIC-PEPTIDE (ANP) RELEASE
    KINGSWOOD, JC
    WOOLF, AS
    LEWIS, CA
    MOULT, PJA
    THOMPSON, FD
    [J]. CLINICAL SCIENCE, 1987, 73 : P25 - P25
  • [39] ACUTE HEMODYNAMIC-EFFECT OF ATRIAL-NATRIURETIC-PEPTIDE (ANP)
    FERNANDEZCRUZ, A
    CARAMELO, C
    VILLAMEDIANA, LM
    SANZ, E
    RODRIGUEZPUYOL, D
    LOPEZNOVOA, JM
    [J]. KIDNEY INTERNATIONAL, 1986, 29 (01) : 383 - 383
  • [40] RADIOIMMUNOASSAY FOR ATRIAL-NATRIURETIC-PEPTIDE (ANP) IN HUMAN-PLASMA
    PANDIAN, MR
    LAM, RW
    CASTRO, L
    FISHER, DA
    [J]. CLINICAL CHEMISTRY, 1986, 32 (06) : 1071 - 1071